Figure 3 - Adoptive immunotherapy strategies with gene-modified T cells and HS cells.

Gene transfer approaches have tested engineered T cells and HS cells. Lymphodepletion enhances engraftment of both cell types. Other strategies under consideration include the use of common lymphoid progenitor cells (CLPs). PBMC, peripheral blood mononuclear cell.

Katie Ris-Vicari